Mind the gap-missing device on the shelf? Retrospective experience with 5/7 Occlutech duct Occluder.
Acta Paediatr
; 113(4): 812-817, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-38149770
ABSTRACT
AIM:
To describe our initial experience with the indications and results of the 5/7 Occlutech® duct Occluder (ODO, Occlutech International AB, Helsingborg, Sweden). A small incremental increase in occluder sizes is of utmost importance for successful outcomes, especially in smaller patients in whom protrusion of the distal disk towards the aorta should be minimised.METHODS:
Retrospective study of all patients undergoing PDA closure with the 5/7 ODO in three institutions since 2018.RESULTS:
The 5/7 ODO was used in 18 patients with median age and weight at the time of the procedure of 17.5 months (interquartile range 25th to 75th percentile 8 months- 4.4 years) and 13.6 kg (interquartile range 25th to 75th percentile 6.4-22.5 kg) respectively. All cases were successful. There were no cases of device embolisation, haemolysis, or flow disturbance of the LPA or the aorta.CONCLUSIONS:
This small retrospective study demonstrated an excellent outcome of transcatheter PDA closure with the 5/7 ODO. The device is a beneficial complement to the existing sizes of PDA devices, filling the gap between the 4/6 and 6/8 ODO and avoiding protrusion of a larger disk in the aortic isthmus.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Conducto Arterioso Permeable
/
Dispositivo Oclusor Septal
Límite:
Child, preschool
/
Humans
Idioma:
En
Revista:
Acta Paediatr
Año:
2024
Tipo del documento:
Article
País de afiliación:
Suecia